ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Erratum to: Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer
Investigational New Drugs
◽
10.1007/s10637-014-0069-6
◽
2014
◽
Vol 32
(3)
◽
pp. 575-575
Author(s):
Carolyn D. Britten
◽
Alex A. Adjei
◽
Robert Millham
◽
Brett E. Houk
◽
Gary Borzillo
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Small Molecule
◽
Phase I Study
◽
Dual Inhibitor
Download Full-text
Related Documents
Cited By
References
Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer
Investigational New Drugs
◽
10.1007/s10637-013-0062-5
◽
2014
◽
Vol 32
(3)
◽
pp. 510-517
◽
Cited By ~ 42
Author(s):
Carolyn D. Britten
◽
Alex A. Adjei
◽
Robert Millham
◽
Brett E. Houk
◽
Gary Borzillo
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Small Molecule
◽
Phase I Study
◽
Dual Inhibitor
Download Full-text
First-In-Human Phase I Study of a Next-Generation, Oral, Transforming Growth Factor-Beta Receptor 1 Inhibitor, LY3200882 in Patients with Advanced Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-1504
◽
2021
◽
pp. clincanres.1504.2021
Author(s):
Timothy A. Yap
◽
María Vieito
◽
Capucine Baldini
◽
Juan Manuel Sepúlveda-Sánchez
◽
Shunsuke Kondo
◽
...
Keyword(s):
Growth Factor
◽
Phase I
◽
Advanced Cancer
◽
Transforming Growth Factor Beta
◽
Phase I Study
◽
Transforming Growth Factor
◽
Next Generation
◽
Beta Receptor
◽
Growth Factor Beta
Download Full-text
PHASE I STUDY OF SYSTEMIC LYMPHOKINE (LCL-LK) ADMINISTRATION IN ADVANCED CANCER PATIENTS
Human Lymphokines
◽
10.1016/b978-0-12-406080-7.50056-4
◽
1982
◽
pp. 633-639
◽
Cited By ~ 1
Author(s):
Joaquim Gouveia
◽
Patricia Ribaud
◽
Antoine Goutner
◽
Georges Mathé
Keyword(s):
Phase I
◽
Cancer Patients
◽
Advanced Cancer
◽
Phase I Study
◽
Advanced Cancer Patients
Download Full-text
Abstract C237: A phase I study of the alternating administration of ixabepilone and vinflunine every three weeks in patients with advanced cancer
10.1158/1535-7163.targ-09-c237
◽
2009
◽
Author(s):
Tarek Mekhail
◽
Ram Ganapathi
◽
Leila Alland
◽
Claude George
◽
Pasquale Benedetto
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Phase I Study
Download Full-text
Abstract CT011: First-in-human Phase I study of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase-1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid malignancies
10.1158/1538-7445.sabcs18-ct011
◽
2019
◽
Cited By ~ 1
Author(s):
Kyriakos Papadopoulos
◽
Paul Eder
◽
Sarina A. Piha-Paul
◽
Claude Gimmi
◽
Elizabeth Hussey
◽
...
Keyword(s):
Phase I
◽
Phase I Study
◽
Dual Inhibitor
◽
Indoleamine 2,3 Dioxygenase
◽
Solid Malignancies
Download Full-text
Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
Journal for ImmunoTherapy of Cancer
◽
10.1186/2051-1426-3-s2-p148
◽
2015
◽
Vol 3
(S2)
◽
Cited By ~ 1
Author(s):
Brendan D Curti
◽
Emmanuel Akporiaye
◽
Kim Sutcliffe
◽
Keith S Bahjat
◽
Yoshinobu Koguchi
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Phase I Study
Download Full-text
666. Phase I Study Results of pbi-shRNA™ STMN1 Nanoplex Via Intratumoral Injection in Advanced Cancer
Molecular Therapy
◽
10.1016/s1525-0016(16)35679-9
◽
2014
◽
Vol 22
◽
pp. S257-S258
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Phase I Study
◽
Intratumoral Injection
◽
Study Results
Download Full-text
A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study
Oncology
◽
10.1159/000065060
◽
2002
◽
Vol 62
(4)
◽
pp. 299-304
◽
Cited By ~ 12
Author(s):
Kristen N. Ganjoo
◽
Michael S. Gordon
◽
Alan B. Sandler
◽
Ruth E. Warner
◽
Karen Fife
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Phase I Study
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase I study of temozolomide in paediatric patients with advanced cancer
British Journal of Cancer
◽
10.1038/bjc.1998.555
◽
1998
◽
Vol 78
(5)
◽
pp. 652-661
◽
Cited By ~ 99
Author(s):
EJ Estlin
◽
◽
L Lashford
◽
S Ablett
◽
L Price
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Phase I Study
◽
Paediatric Patients
Download Full-text
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-17-1922
◽
2018
◽
Vol 24
(8)
◽
pp. 1816-1823
◽
Cited By ~ 52
Author(s):
Neil H. Segal
◽
Aiwu R. He
◽
Toshihiko Doi
◽
Ronald Levy
◽
Shailender Bhatia
◽
...
Keyword(s):
Phase I
◽
Advanced Cancer
◽
Phase I Study
◽
Single Agent
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close